Listeria Infections
Also known as: Listeriosis
Methodology & AI Transparency ⓘ
Listeria Infections Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Listeriosis is a foodborne illness caused by Listeria monocytogenes, bacteria found in soil and water.
- 2 Real-world patient consensus: Clinical coding for Listeria Infections uses ICD-10 A32.9 across Infections & Antivirals specialty care.
- 3 Typical cash cost range: Primary evaluation for Listeria Infections incorporates sepsis/severity red-flag triage [Listeria Infections A32.9] and symptom diary review.
- 4 Top reported side effects / signs: Key Infections & Antivirals biomarkers for Listeria Infections (A32.9): C-Reactive Protein / in Listeria Infections (A32.9: Procalcitonin) & Targeted PCR / in Listeria Infections (A32.9: Culture & Sensitivity) (Pathogen clearance / negative test (A32.9)).
Ask our AI Specialists anything about Listeria Infections
What Is Listeria Infections?
Listeriosis is a foodborne illness caused by Listeria monocytogenes, bacteria found in soil and water. It can be in a variety of raw foods as well as in processed foods and foods made from unpasteurized milk. Listeria is unlike many other germs because it can grow even in the cold temperature of the refrigerator. Symptoms include fever and chills, headache, upset stomach and vomiting. Treatment is with antibiotics. Anyone can get the illness. But it is most likely to affect pregnant women and unborn babies, older adults, and people with weak immune systems.
Pathophysiology, Underlying Causes & Clinical Presentation
Biological expression of Listeria Infections (A32.9, Infections & Antivirals) reflects or latent viral in Listeria Infections (A32.9: reactivation within sensory). Cross-referenced with NIH MeSH (Listeriosis), longitudinal control is benchmarked via C-Reactive Protein / in Listeria Infections (A32.9: Procalcitonin).
Common Symptoms & Clinical Signs
- • Use precooked and ready-to-eat foods as soon as you can
- • Avoid raw milk and raw milk products
- • Presentation of Listeria Infections (A32.9): regional lymph node in Listeria Infections (A32.9: tenderness or acute)
- • Secondary Listeria Infections clinical sign: acute fever, chills, in Listeria Infections (A32.9: malaise, and myalgias)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Listeria Infections Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | A32.9 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Bacterial, Viral & Fungal Infections | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: C-Reactive Protein / in Listeria Infections (A32.9: Procalcitonin) | Resolution to baseline (A32.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Targeted PCR / in Listeria Infections (A32.9: Culture & Sensitivity) | Pathogen clearance / negative test (A32.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Complete Blood Count in Listeria Infections (A32.9: (WBC & Differential)) | WBC 4.0 – 10.0 x10^3/uL (A32.9) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Listeria Infections
Treatment selection for Listeria Infections depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Listeria Infections)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Comparative Emergence of Maribavir and Ganciclovir Resistance in a Randomized: What a 241-Participant Study Found After 3-8 weeks of therapy, maribavir resistance emerged earlier and more frequently than ganciclovir resistance but was usually treatable using alternative therapy. The Journal of infectious diseases • 2025-03-17 • Phase III Randomized Trial | N = 241 | 82/100 | PMID 39302855 ↗ |
| Can This Approach Help? Inside the Latest Research on Cefiderocol for the Treatment of Infections Due to Metallo-B-lactamase-Producing In the CREDIBLE-CR and APEKS-NP. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America • 2022-09-29 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 35148378 ↗ |
Listeria Infections Patient Community & “People Like Me” Threads
Filter Listeria Infections community threads and patient logs by age, biological sex, dosage, and treatment duration.